Maintained ipsilateral SRF (N = 899) | Decreased ipsilateral SRF (N = 179) | p-value | |
---|---|---|---|
Age (years) | 60.5 ± 12.7 | 61.5 ± 13.3 | 0.363 |
Sex (n, %) | 0.531 | ||
Male | 608 (68.0) | 126 (70.4) | |
Female | 286 (32.0) | 53 (29.6) | |
HTN (n, %) | 458 (51.1) | 90 (50.3) | 0.838 |
DM (n, %) | 193 (21.5) | 38 (21.2) | 0.926 |
Dyslipidemia (n, %) | 191 (21.2) | 35 (19.6) | 0.673 |
Liver disease | 97 (10.8) | 20 (11.2) | 0.992 |
Tuberculosis | 40 (4.4) | 8 (4.5) | 1.000 |
BMI (kg/m2) | 25.4 ± 3.54 | 25.2 ± 3.64 | 0.636 |
Preoperative lab | |||
Creatinine (mg/dL) | 1.00 ± 2.72 | 1.02 ± 0.78 | 0.942 |
eGFR (mL/min/1.73 m2) | 84.8 ± 22.5 | 81.3 ± 24.3 | 0.073 |
Operative method (n, %) | < 0.001 | ||
Partial nephrectomy | 781 (87.2) | 133(74.3) | |
Radical nephrectomy | 78 (12.8) | 38 (25.7) | |
Tumor size (cm) | 3.31 ± 2.15 | 6.85 ± 3.25 | < 0.001 |
T stage (n, %) | < 0.001 | ||
T1–T2 | 815 (91.0) | 143 (79.9) | |
T3–T4 | 91 (9.0) | 36 (20.1) | |
Fuhrman grade (n, %) | 0.001 | ||
Grade 1–2 | 521 (58.3) | 79 (44.4) | |
Grade 3–4 | 372 (41.7) | 99 (55.6) | |
Pathology (n, %) | 0.357 | ||
Clear cell | 756 (83.9) | 145 (81.0) | |
Non-clear cell | 143 (16.1) | 34 (19.0) | |
Ipsilateral GFR (ml/min) | 44.0 ± 13.8 | 34.6 ± 13.4 | < 0.001 |